# Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

Study · id `cardio:ct-nct06526195` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06526195](<https://clinicaltrials.gov/study/NCT06526195>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06526195

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease; Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 850 participants.

## Technical summary

Registry record NCT06526195. Randomized; no masking; primary purpose treatment. Start 2024-12-13 (actual); primary completion 2029-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 850 participants (planned count; ClinicalTrials.gov record NCT06526195, source copy `cardio:ctgov-nct06526195-2026-11-05`, retrieved 2026-11-18)
- Started: 2024-12-13 (actual) (ClinicalTrials.gov record NCT06526195, source copy `cardio:ctgov-nct06526195-2026-11-05`, retrieved 2026-11-18)
- Primary completion: 2029-09 (anticipated) (ClinicalTrials.gov record NCT06526195, source copy `cardio:ctgov-nct06526195-2026-11-05`, retrieved 2026-11-18)
- Completion: 2032-09 (anticipated) (ClinicalTrials.gov record NCT06526195, source copy `cardio:ctgov-nct06526195-2026-11-05`, retrieved 2026-11-18)
- Countries: United States; Austria; Czechia; Denmark; Germany; Italy; Netherlands; Saudi Arabia (ClinicalTrials.gov record NCT06526195, source copy `cardio:ctgov-nct06526195-2026-11-05`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06526195-2026-11-05`, retrieved 2026-11-18)

## The registry's words

- Brief title: Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Acronym: TEAM-HF
- Condition: Heart Failure
- Condition: Heart Diseases
- Condition: Cardiovascular Diseases
- Condition: Pulmonary Hypertension
- Intervention (Device): CardioMEMS HF System
- Intervention (Device): HeartMate 3 Left Ventricular Assist System
- Intervention (Other): Guideline Medical Directed Therapy
- Lead sponsor: Abbott Medical Devices
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Pulmonary hypertension (`cardio:pulmonary-hypertension`)
- Registry intervention name matches this record: CardioMEMS HF System (`cardio:cardiomems-hf-system`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)

## Provenance

Content hash: caa8197e43c4afc35d84259f544f4656550c113a32066ae247ff7c3f0952e240
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
